doxorubicin hydrochloride,brentuximab,dacarbazine,filgrastim,pegfilgrastim,nivolumab,vinblastine sulfate
seagen,amgen,bms,pfizer,merck
[]
(=> ASCO: $SGEN top-selling drug under threat as $BMY Opdivo beats Adcetris in lymphoma 

=> Oh my. $43 billion $PFE. Smartest thing $MRK did - was to take a walk.
We cannot direct the wind, but we can adjust the sails... Family Office. Founder Princeton Biomedical Consul. LLC.